Search Results

Metastatic Melanoma: Symptoms, Diagnoses, and Treatments

• Authors : Beckler, James P.; Klein, Sarah A.

Subjects: Metastasis; MelanomaMEDICAL / Oncology / General; HEALTH & FITNESS / Diseases & Conditions / Cancer

Record details

Medication patterns and potentially inappropriate medication in patients with metastatic breast cancer: results of the BRE-BY-MED study.

• Authors : Brandstetter, Lilly Sophia¹ (AUTHOR) ; Grau, Anna¹ (AUTHOR); Heuschmann, Peter U.^1,2 (AUTHOR)

• Source: BMC Cancer. 1/22/2025, Vol. 25, p1-15. 15p.

Record details

Motivations and perceptions for physical activity in women living with metastatic breast cancer: a qualitative interview study.

• Authors : Liu, Mark¹ (AUTHOR); Kilbreath, Sharon¹ (AUTHOR); Yee, Jasmine^1,2 (AUTHOR)

• Source: BMC Cancer. 1/14/2025, Vol. 25 Issue 1, p1-8. 8p.

Record details

Personal and behavioural factors that influence physical activity in women living with metastatic breast cancer: a qualitative interview study.

• Authors : Liu, Mark¹ (AUTHOR); Kilbreath, Sharon¹ (AUTHOR); Yee, Jasmine^1,2 (AUTHOR)

• Source: BMC Cancer. 1/9/2025, Vol. 25 Issue 1, p1-9. 9p.

Record details

Bacterial membrane-modified cerium oxide nanoboosters enhance systemic antitumor effects of radiotherapy in metastatic triple-negative breast cancer.

• Authors : Chen, Shuo-Fu¹ (AUTHOR); Ng, Pui-Lam² (AUTHOR); Lai, Chen-Wei² (AUTHOR)

• Source: Journal of Nanobiotechnology. 2/12/2025, Vol. 23 Issue 1, p1-18. 18p.

Record details

Tumor characteristics and survival rate of axillary metastatic breast cancer patients: a three decades retrospective cohort study.

• Authors : Mousavi-kiasary, Seyed Mohamad Sadegh^1,2 (AUTHOR); Bayat, Mahdis^2,3 (AUTHOR); Abbasvandi, Fereshteh^2,4 (AUTHOR)

• Source: Scientific Reports. 2/7/2025, Vol. 15 Issue 1, p1-13. 13p.

Record details

WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.

• Authors : Berneman, Zwi N.^1,2,3 (AUTHOR) ; De Laere, Maxime^1,2,3 (AUTHOR) ; Germonpré, Paul⁴ (AUTHOR)

• Source: Journal of Hematology & Oncology. 1/23/2025, Vol. 18 Issue 1, p1-6. 6p.

Record details

Impacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in patients with metastatic breast cancer.

• Authors : Huang, Riqing^1,2 (AUTHOR); Hu, Anqi^1,2 (AUTHOR); Rong, Qixiang^1,2 (AUTHOR)

• Source: Journal of Translational Medicine. 1/13/2025, Vol. 23 Issue 1, p1-11. 11p.

Record details

Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer.

• Authors : Ceylan, Furkan¹ (AUTHOR) ; Mehdiyev, Mirmehdi¹ (AUTHOR); Dede, Didem Şener^1,2 (AUTHOR)

• Source: Journal of Clinical Medicine. Jan2025, Vol. 14 Issue 1, p173. 15p.

Record details

Systematic Review and Network Meta-Analysis on Treating Hormone Receptor-Positive Metastatic Breast Cancer After CDK4/6 Inhibitors.

• Authors : Pathak, Neha^1,2 (AUTHOR); Mittal, Abhenil³ (AUTHOR); Kumar, Sudhir^2,4 (AUTHOR)

• Source: Current Oncology. Jan2025, Vol. 32 Issue 1, p53. 30p.

Record details